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Abstract
A short time to positivity (TTP) correlates with poor clinical outcome in patients with Staphylococcus aureus bacteraemia, but the association
between sequential TTPs and the outcome of these patients is unclear. Sequential TTPs from patients with S. aureus bacteraemia persisting
for >48 h were analysed with respect to clinical parameters and patient outcome at a tertiary hospital. During the 5-year study period, 87
patients (9.2%; mean age of 64 years) had persistent S. aureus bacteraemia, with an average Pittsburgh bacteraemia score of 2.7. Forty-eight
patients (55%) had methicillin-resistant S. aureus infection, and 28 (32%) had nosocomial infection. The most common underlying disease
was end-stage renal disease (43%). The most common type of infection was catheter-related infection (31%), followed by infective
endocarditis (18%). The in-hospital mortality rate was 40%. Higher Pittsburgh scores (p 0.005; OR 1.37; 95% CI 1.1–1.7) and a second TTP/
ﬁrst TTP ratio of <1.5 (p 0.004; OR 0.2; 95% CI 0.07–0.6) were independent risk factors for mortality. Among patients receiving adequate
empirical therapy, a second positive blood culture growing within 12 h was more frequent in patients who ﬁnally died. Factors associated
with a second TTP/ﬁrst TTP ratio of <1.5 included older age (p 0.02; OR 0.96; 95% CI 0.92–0.99) and inadequate empirical antimicrobial
therapy (p 0.01; OR 3.53; 95% CI 1.42–8.78). Among patients with persistent S. aureus bacteraemia, a second TTP/ﬁrst TTP ratio of <1.5 is
a predictor of poor outcome. Physicians should search for interventions guaranteeing that all patients with S. aureus bacteraemia receive
adequate empirical therapy.
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Introduction
Persistent Staphylococcus aureus bacteraemia is not uncommon,
especially in patients with endovascular infection or metastatic
foci [1–4]. To ascertain the clearance of S. aureus bacteraemia,
Infectious Diseases Society of America guidelines recommend
follow-up blood cultures 2–4 days after the initial positive
culture [1]. Early removal of implicated catheters or other
devices, and eradication of infected foci, are crucial for
decreasing the chance of persistent bacteraemia [5,6].
In a clinical setting, a positive blood culture after 48 h of
antibiotic treatment does not necessarily indicate treatment
failure. The time to positivity (TTP) of blood culture is a
parameter that reﬂects the bacterial load in the bloodstream.
Several reports have shown that a short TTP is correlated with
poor clinical outcome [7–9]. However, there is only limited
information about the TTP in patients with persistent S. aureus
bacteraemia [10]. In our previous case report, the TTP of
blood cultures did not increase in a patient with persistent
S. aureus bacteraemia, despite administration of appropriate
antimicrobial agents for >30 days. The bacteraemia resolved
only after repeated surgical debridement, removal of cathe-
ters, and the use of linezolid.
On the basis of this previous experience, we postulated that
changes in sequential blood culture TTPs might provide insights
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into whether a patient is responding to treatment. To explore
this possibility, we analysed the TTPs of blood cultures from 87
consecutive patients with S. aureus bacteraemia persisting for
>48 h, and studied the correlation with patient outcomes.
Patients and Methods
Hospital setting and patients
From January 2007 to December 2011, we enrolled 87
consecutive patients who had S. aureus bacteraemia persisting
for >48 h at our institution, a 1080-bed tertiary-care facility in
northern Taiwan. Patients with S. aureus bacteraemia were
identiﬁed with the BACTEC 9240 automated detection blood
culture system (Becton Dickinson Diagnostic Instrument
Systems, Sparks, MD, USA). Time to blood culture positivity
for each patient was determined by the blood culture
instrument. At our institute, a follow-up blood culture is
usually performed when patients have persistent clinical
symptoms, such as fever, >48 h after initiation of treatment.
Patients whose follow-up blood cultures indicated S. aureus
infection were enrolled in our study. Each patient was included
only once. We excluded patients who were aged <18 years,
had polymicrobial bacteraemia, or were not admitted to our
hospital. Clinical information was collected from the medical
records. Severity of bacteraemia was assessed according to the
Pittsburgh bacteraemia score [11].
Identiﬁcation of S. aureus and TTP of blood cultures
Blood samples (approximately 10 mL) were taken and inoc-
ulated into aerobic and anaerobic culture ﬂasks, and incubated
in the automated detection blood culture system. All samples
were loaded into the machine upon arrival at the central
laboratory. The BACTEC 9240 system monitors CO2 pro-
duction continuously at 10-min intervals, and positivity is
indicated by means of a ﬂuorescent signal. The TTP is
automatically recorded by the machine. Identiﬁcation of
S. aureus was based on the morphology of colonies, the
results of Gram staining, and a positive tube coagulase test
result. Susceptibility of isolates was determined with the disk
diffusion method [12]. TTP, deﬁned as the time from the start
of incubation to the start of the alert signal, was recorded for
each positive sample. For a patient with multiple sets of
positive blood cultures, the shortest TTP was selected. Blood
cultures collected from central venous catheters were not
excluded [7].
Clinical parameter deﬁnitions
Infective endocarditis was deﬁned according to modiﬁed
Duke’s criteria [13]. Catheter-related bloodstream infection
(CRBSI) was deﬁned according to the results of tip culture
and/or the differential time method [14]. Pneumonia was
deﬁned as a positive sputum culture and the presence of newly
developed lung inﬁltrates. If no focus could be identiﬁed, the
bacteraemia was classiﬁed as primary. In-hospital mortality was
used as the patient outcome. All patients were followed until
they were discharged. The appropriateness of empirical
antibiotics was evaluated according to the susceptibility results.
The administration of effective antibiotics within the initial
24 h after blood samples were collected was considered to be
adequate empirical therapy. We classiﬁed blood cultures
collected from 48 h to 7 days after the initial blood culture
as the second blood culture, and those collected 8–14 days
after the initial blood culture as the third blood culture.
Statistical analysis
The demographic characteristics were compared between
surviving and deceased patients with univariate analysis. ORs
and 95% CIs were calculated. A logistic regression model was
used for multivariate analyses, to determine the independent
factors for mortality. The variables entered into multivariate
analysis were selected on the basis of the results of univariate
analysis, previous study results, and possible biological asso-
ciations. Data were analysed with SPSS software for Windows
(Release 15.0; SPSS, Chicago, IL, USA).
Results
Study populations
During the 5-year study period, 943 patients had S. aureus
bacteraemia, and 87 patients (9.2%) had persistent bacteraemia
and met our enrolment criteria. The mean age was 64 years
(64.3  16.2 years; range, 20–92 years), and the average
Pittsburgh bacteraemia score was 2.7 (2.7  2.5; range, 0–
12). Forty-eight patients (55%) had methicillin-resistant
S. aureus (MRSA) infection, and 28 patients (32%) had noso-
comial infection. The most common major underlying disease
was end-stage renal disease (ESRD) (43%). All ESRD patients
were receiving haemodialysis, and 25 (68%) had MRSA
bacteraemia.
The most common cause of persistent bacteraemia was
CRBSI (31%), followed by infective endocarditis (18%). Among
the 27 patients with CRBSI, 21 infections resulted from
permanent catheters, four from double-lumen catheters, and
two from central venous catheters. The average time between
permanent catheter insertion and the ﬁrst positive blood
culture was 274 days (range, 7–1234 days; median, 64 days).
Twenty-ﬁve patients (93%) had index catheter removal within
5 days (4.9  4.5 days; range, 0–18 days), and ﬁve of them
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had catheters removed within 48 h of the ﬁrst positive blood
culture. Twelve patients had positive blood cultures after-
wards, in spite of catheter removal. There were 23 patients
who underwent surgical intervention, with an average interval
of 11 days (10.6  12.6 days; range, 0–55 days) between the
ﬁrst positive blood culture and surgery. The bacteraemia
cleared in 19 of these patients after intervention.
The mean TTP of the ﬁrst blood culture was 12.6 h
(12.6  8.2 h; range, 3.5–63.2 h), and that of the second was
24.7 h (24.7  16.7 h; range, 4.9–89.4 h). Blood samples for
the second culture were drawn an average of 4 days
(3.8  1.7 days; range, 3–7 days) after the initial blood
culture. The TTP of the second culture increased 1.5-fold
over that of the ﬁrst culture in 54 patients (62%).
Risk factors for in-hospital mortality
The in-hospital mortality rate was 40%, and the average time
from the ﬁrst positive culture to death was 21 days
(21.2  18.5 days; range, 3–77 days). We analysed risk factors
for in-hospital mortality (Table 1). Signiﬁcant risk factors in
univariate analysis included a higher Pittsburgh bacteraemia
score (p 0.01; OR 1.37; 95% CI 1.07–1.58), surgical interven-
tion (p 0.04; OR 0.31; 95% CI 0.1–0.95), a second TTP of
<12 h (p 0.02; OR 7.40; 95% CI 1.47–37.38), and a 1.5-fold
increase in the second TTP as compared with the ﬁrst TTP
(p 0.04; OR 0.38; 95% CI 0.16–0.94). Patients with pneumonia
or empyema had a borderline increased risk of mortality
(p 0.05; OR 5.17; 95% CI 0.98–27.32). In multivariate analysis,
only a higher Pittsburgh bacteraemia score (p 0.005; OR 1.37;
95% CI 1.10–1.73) and 1.5-fold increase in the second TTP
(p 0.004; OR 0.20; 95% CI 0.07–0.59) were found to be
independent risk factors for mortality. A TTP of <12 h for
the ﬁrst blood culture was not a signiﬁcant risk factor for
mortality in our study.
Analysis of mortality rate stratiﬁed according to the second
TTP/ﬁrst TTP ratio
Mortality rates according to the second TTP/ﬁrst TTP ratio
are compared in Fig. 1. Fifteen patients had a shorter second
TTP than ﬁrst TTP, and the in-hospital mortality rate was 60%.
If the cut-off for the second TTP/ﬁrst TTP ratio was set at
>1.5, the mortality rates were 55% for patients with a ratio of
<1.5 and 31% for those with a ratio of >1.5 (p 0.04).
Analysis of mortality rate among patients receiving adequate/
inadequate empirical therapy
Patients who received adequate empirical therapy but still had
persistent bacteraemia (n = 53) were analysed. Among these
patients, 18 (34%) died. A higher Pittsburgh bacteraemia score
was still a predictor of mortality (4.8  0.7 vs. 1.9  0.3,
p <0.01). A second TTP/ﬁrst TTP ratio of <1.5 was seen in
67% of the deceased group and in 77% of the surviving group
TABLE 1. Comparison of variables between deceased and surviving patients with Staphylococcus aureus bacteraemia persisting
for >48 h
Survived, n = 52 (%) Deceased, n = 35 (%)
Univariate
p-value
Multivariate
p-value OR (95% CI)
Age (years) 62.4  16.1 (range, 20–89) 67.1  16.3 (range, 31–92) 0.19 0.48 1.01 (0.98–1.04)
Male gender 27 (52) 22 (63) 0.31
Hospital acquisition 14 (27) 14 (40) 0.20
MRSA 28 (54) 20 (57) 0.76
Underlying diseases
Diabetes mellitus 32 (62) 20 (57) 0.68
ESRD 24 (46) 13 (37) 0.41
Malignancy 7 (14) 5 (14) 0.91
Liver cirrhosis 3 (6) 4 (11) 0.35
Pittsburgh bacteraemia score 2.1  2.1 3.6  2.8 0.01 0.005 1.37 (1.10–1.73)
Focus of infection
Catheter 17 (30) 10 (28) 0.68
IE 8 (15) 8 (23) 0.38
Bone and soft tissue 11 (21) 3 (9) 0.13
Pneumonia/empyema 2 (4) 6 (17) 0.05 0.17 3.84 (0.57–25.76)
Vascular other than IE 7 (14) 1 (3) 0.19 0.9
Primary bacteraemia 2 (4) 4 (10) 0.19
Intra-abdominal infection 2 (4) 2 (5) 0.69
Other* 3 (5) 1 (4) 0.48
Intervention
Catheter removal 17 (33) 9 (26) 0.49
Catheter removal within 48 h 3 (6) 2 (6) 0.49
Surgical intervention 18 (35) 5 (14) 0.04 0.75 0.81 (0.22–3.0)
Adequate empirical therapy 35 (67) 18 (51) 0.14
TTP
First TTP of <12 h 32 (62) 22 (63) 0.90
Second TTP of <12 h 2 (3) 8 (23) 0.02
Second TTP/ﬁrst TTP ratio of >1.5 37 (71) 17 (49) 0.04 0.004 0.20 (0.07–0.59)
ESRD, end-stage renal disease; IE, infective endocarditis; MRSA, methicillin-resistant Staphylococcus aureus; TTP, time to positivity.
*Included urinary tract infection, purulent pericarditis, mediastinitis, and epidural abscess.
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(p 0.51). A second TTP of <12 h was seen in 17% of the
deceased group and in 3% of the surviving group (p 0.11).
Among patients receiving inadequate empirical therapy, the
mortality rate was 50%. Deceased patients were older
(71 years vs. 63 years, p 0.17) and more often had a second
TTP of <12 h (29% vs. 6%, p 0.18). A second TTP/ﬁrst TTP
ratio of <1.5 was seen in 71% of the deceased group and in
41% of the surviving group (p 0.17).
Factors associated with a difference between the ﬁrst and
second TTPs
The characteristics of patients with and without a 1.5-fold
increase in the second TTP were analysed (Table 2). Older age
(p 0.01; OR 0.95; 95% CI 0.92–0.99) and ESRD (p 0.03;
OR 0.37; 95% CI 0.15–0.90) were signiﬁcantly associated with
a < 1.5-fold increase in the second TTP. In contrast, adequate
empirical antimicrobial therapy (p 0.01; OR 3.53;
95% CI 1.42–8.78) was associated with a >1.5-fold increase
in the second TTP. In multivariate analysis, older age (p 0.02;
OR 0.96; 95% CI 0.92–0.99) and adequate empirical antimi-
crobial therapy (p 0.02; OR 3.11; 95% CI 1.18–8.20) were
independent factors.
Factors associated with a positive third blood culture
There were 32 patients who had blood samples collected 8–
14 days after the initial blood culture; 13 of these patients
(41%) remained positive for S. aureus bacteraemia (Table 3).
The average of the third TTP was 30 h (29.9  23.4 h; range,
7.6–80.6 h). ESRD was the only factor with borderline
signiﬁcance (62% vs. 26%, p 0.05) in univariate analysis. The
percentage of patients with MRSA was higher among those
with a positive third blood culture (92% vs. 68%, p 0.14).
Discussion
In this study, we demonstrated that, among patients with
S. aureus bacteraemia that persisted for >48 h, those with a
less than 1.5-fold increase in the second TTP over the ﬁrst
TTP had a poorer outcome. However, the predictive power of
the second TTP was smaller when we included only patients
who received correct empirical therapy, which supports the
importance of early adequate therapy.
Many studies have discussed risk factors for persistent
S. aureus bacteraemia, deﬁned as S. aureus bacteraemia per-
sisting for ≥7 days [2–4,15,16]. MRSA infection, an intravenous
catheter or foreign body, endovascular involvement, meta-
static foci or underlying chronic kidney disease were reported
as risk factors for persistent bacteraemia [2–4,16]. In this
study, similar risk factors were found. The most common
infection was CRBSI. Although 93% of patients had index
catheter removal within 5 days, only ﬁve of these removals
were performed within 48 h of the ﬁrst positive blood culture.
Early diagnosis of catheter-related infection with the differen-
tial time method and prompt removal of the infected catheter
could decrease the frequency of persistent bacteraemia and
further complications [5,14]. A less than 1.5-fold increase in
the second TTP could be used as an early sign of ineffective
treatment [10].
Khatib et al. [7] ﬁrst showed that the TTP of S. aureus
bacteraemia correlates with the outcome and focus of
infection. Several studies have also demonstrated the predic-
tive value of TTP with different cut-off values (12 h and 14 h)
[8,9]. However, in our study, a ﬁrst TTP of <12 h was not a
good predictor of mortality. On the other hand, a second
FIG. 1. Mortality rates stratiﬁed according to second time to positivity (TTP)/ﬁrst TTP ratio.
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TTP of <12 h was strongly associated with mortality. This
ﬁnding raises important issues regarding the use of TTP as a
predictor of outcome. First, all of the patients in this study
had bacteraemia persisting for >48 h, and patients who died
within 48 h were excluded. Thus, the association between a
shorter ﬁrst TTP and poorer outcome might not have been
demonstrated. Second, we did not exclude TTPs of blood
samples collected from central catheters. For cathe-
ter-related infection, the TTP will be shorter [14], but the
outcome of catheter-related infection is better than of other
difﬁcult-to-treat infections, such as endocarditis and pneu-
monia [17]. If TTPs of samples collected from catheters are
not excluded [7], the predictive power of TTP might be
compromised.
Third, the timing of blood culture collection varies, and this
might affect the TTP value. Theoretically, blood samples should
be collected immediately after the patient develops chills.
However, the effect of the timing of collection on TTP has not
been systematically analysed [18]. According to the Infectious
Diseases Society of America guideline, blood cultures should
be repeated [1], but the best timing is not addressed. In this
study, the timing of the second blood culture was determined
by the primary-care physician, usually after the patient
developed a fever.
Fourth, in the emergency department, blood samples tend
to be collected later in the course of fever/chills than those
collected in the ward or intensive-care unit, and are associated
with longer TTPs [19]. Moreover, bacteraemia detected in the
TABLE 2. Factors associated with second time to positivity (TTP)/ﬁrst TTP ratio
Variables
Second TTP/ﬁrst
TTP ratio of > 1.5,
n = 54 (%)
Second TTP/ﬁrst
TTP ratio of ≤ 1.5,
n = 33 (%)
Univariate
p-value
Multivariate
p-value OR (95% CI)
Age (years) 60.4  16.8 (range, 20–92) 70.7  13.1 (range, 32–87) 0.01 0.02 0.96 (0.92–0.99)
Hospital acquisition 15 (28) 13 (39) 0.26
MRSA 26 (48) 22 (67) 0.09
ESRD 18 (32) 20 (53) 0.03 0.25 0.56 (0.21–1.48)
Malignancy 4 (7) 8 (21) 0.13
Pittsburgh bacteraemia score 3.0  2.7 2.2  2.0 0.09
Intervention
Catheter removal 16 (30) 10 (30) 0.95
Catheter removal within 48 h 3 (6) 2 (6) 0.95
Surgical intervention 16 (30) 7 (21) 0.39
Adequate empirical therapy 39 (68) 14 (37) 0.01 0.02 3.11 (1.18–8.20)
Focus of infection
Catheter 16 (30) 11 (33) 0.72
IE 11 (20) 5 (15) 0.54
Bone and soft tissue 9 (17) 5 (15) 0.85
Pneumonia/empyema 5 (9) 3 (9) 0.98
Vascular other than IE 4 (7) 4 (12) 0.46
Primary bacteraemia 2 (4) 4 (12) 0.15
Intra-abdominal 4 (7) 0 (0) 0.29
Other 3 (6) 1 (3) 0.59
ESRD, end-stage renal disease; IE, infective encocarditis; MRSA, methicillin-resistant Staphylococcus aureus.
Variables
Positive third
culture, n = 13 (%)
Negative third
culture, n = 19 (%)
Univariate
p-value
Age (years) 68.8  6.5 (range, 54–76) 59.8  17.7 (range, 20–92) 0.11
Hospital acquisition 7 (54) 7 (37) 0.34
MRSA 12 (92) 13 (68) 0.14
ESRD 8 (62) 5 (26) 0.05
Malignancy 2 (15) 3 (16) 0.98
Pittsburgh bacteraemia score 2.6  2.4 2.5  2.7 0.92
Intervention
Catheter removal 6 (46) 5 (26) 0.25
Surgical intervention 5 (39) 4 (21) 0.29
Adequate empirical therapy 8 (62) 8 (42) 0.28
Focus of infection
Catheter 6 (46) 6 (32) 0.41
IE 3 (23) 2 (11) 0.35
Bone and soft tissue 1 (8) 3 (16) 0.50
Pneumonia/empyema 1 (8) 2 (11) 0.79
Vascular other than IE 2 (15) 2 (11) 0.68
Primary bacteraemia 0 (0) 2 (11) 0.50
Other 0 (0) 2 (11) 0.50
TTP
Second TTP of <12 h 0 (0) 1 (5) –
Second TTP/ﬁrst TTP ratio of >1.5 9 (69) 8 (42) 0.78
In-hospital mortality 3 (23) 8 (42) 0.27
ESRD, end-stage renal disease; IE, infective endocarditis; MRSA, methicillin-resistant Staphylococcus aureus; TTP, time to
positivity.
TABLE 3. Comparison of variables
between patients with positive and
negative third blood cultures
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emergency department is associated with a better outcome
[19]. In spite of all these confounding factors, a recent Korean
study demonstrated that patients who had decreases in the
TTPs of follow-up blood cultures experienced higher 30-day
mortality [20], consistent with our observations.
Factors associated with failure of the second TTP to
increase 1.5-fold included older age and inadequate empirical
antimicrobial therapy. Although the positive effect of adequate
empirical therapy for S. aureus bacteraemia is arguably small
[3,21–23], Kim et al. demonstrated that appropriate empirical
therapy could decrease persistent bacteraemia in the ﬁrst
week [22]. Although adequate empirical therapy can effectively
decrease persistent bacteraemia, it is not signiﬁcantly associ-
ated with decreased in-hospital mortality (there is only a
trend). In this study, patients with early mortality (<48 h), for
whom adequate empirical therapy might be of the utmost
importance [24], were not included. Nevertheless, early and
adequate empirical therapy should be the goal for physicians
treating patients with invasive S. aureus infections [1,23].
There are several limitations of this study. First, the timing
of blood sample collection and the sample volumes were not
consistent [18]. The effect of sample collection timing on TTP
requires further research. In contrast, differences in the
volume of blood should have only a minimal impact on TTP, as
bacteria multiply logarithmically. Second, we did not monitor
the time from blood sample collection to the loading of
samples into the machine. There could be a time-lag that
affects the TTP. Third, this was a single-institute study, and the
rate of persistent bacteraemia is relatively low as compared
with previous studies. This could be attributable to the lack of
a protocol for routinely obtaining blood cultures for all
patients with S. aureus bacteraemia.
In conclusion, in patients with persistent S. aureus bacter-
aemia, a second TTP/ﬁrst TTP ratio of <1.5 is a predictor of
poor outcome. Physicians should search for possible inter-
ventions, and adjust antibiotics promptly.
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